Fungaemia in haematological malignancies: SEIFEM‐2015 survey

Fungal infections are still a relevant challenge for clinicians involved in the cure of patients with cancer. We retrospectively reviewed charts of hospitalized patients with haematological malignancies (HMs), in which a documented fungaemia was diagnosed between January 2011 and December 2015 at 28 adult and 6 paediatric Italian Hematology Departments.

[1]  L. Pagano,et al.  Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report , 2017, Haematologica.

[2]  F. Dromer,et al.  The risk and clinical outcome of candidemia depending on underlying malignancy , 2017, Intensive Care Medicine.

[3]  S. Verma,et al.  Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India. , 2015, Hematology/oncology and stem cell therapy.

[4]  M. Paesmans,et al.  Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  H. Kantarjian,et al.  The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. , 2015, The Journal of antimicrobial chemotherapy.

[6]  P. Muñoz,et al.  Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  F. Şimşek,et al.  Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage , 2014, Therapeutics and clinical risk management.

[8]  M. Angelopoulou,et al.  A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  A. Colombo,et al.  Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil , 2013, Mycoses.

[10]  B. Ko,et al.  Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010. , 2012, International journal of antimicrobial agents.

[11]  H. Einsele,et al.  Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors. , 2012, Medical mycology.

[12]  Russell E. Lewis,et al.  Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007) , 2009, Cancer.

[13]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  E. Anaissie,et al.  Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Wingard,et al.  Changes in causes of death over time after treatment for invasive aspergillosis , 2008, Cancer.

[16]  L. Pagano,et al.  Design and Methods , 2022 .

[17]  Nina Singh,et al.  Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  D. Kontoyiannis,et al.  The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  E. Anaissie,et al.  Fusarium infection in hematopoietic stem cell transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  L. Mele,et al.  Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes , 1999, European journal of haematology.

[21]  B. Lebeau,et al.  Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  A. Reboli,et al.  Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.